Does IRBESARTAN Cause Muscular weakness? 319 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 319 reports of Muscular weakness have been filed in association with IRBESARTAN (Irbesartan). This represents 3.1% of all adverse event reports for IRBESARTAN.
319
Reports of Muscular weakness with IRBESARTAN
3.1%
of all IRBESARTAN reports
1
Deaths
284
Hospitalizations
How Dangerous Is Muscular weakness From IRBESARTAN?
Of the 319 reports, 1 (0.3%) resulted in death, 284 (89.0%) required hospitalization, and 235 (73.7%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 319 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which IRBESARTAN Alternatives Have Lower Muscular weakness Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE